[HTML][HTML] Resveratrol in prostate diseases–a short review
M Jasiński, L Jasińska… - Central European journal …, 2013 - ncbi.nlm.nih.gov
Conclusions Resveratrol is produced and sold as a nutritional supplement, there is not
enough clinical evidence to justify a recommendation for the administration of resveratrol in …
enough clinical evidence to justify a recommendation for the administration of resveratrol in …
[HTML][HTML] Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases
M Slupski, Z Wlodarczyk, M Jasinski… - Canadian Journal of …, 2009 - ncbi.nlm.nih.gov
Background The optimal strategy for the treatment of synchronous colorectal liver metastases
has not been established yet. In this study, we present the outcomes and survival rates of …
has not been established yet. In this study, we present the outcomes and survival rates of …
[HTML][HTML] Serum paraoxonase-1 activity and the risk of prostate cancer recurrence in patients treated with radiotherapy
M Jasinski, D Olszewska-Slonina - Antioxidants, 2022 - mdpi.com
The antioxidant paraoxonase-1 (PON1) may be involved in the response to radiation-induced
oxidative stress and possibly prevent cell apoptosis. The correlation of PON1 with the risk …
oxidative stress and possibly prevent cell apoptosis. The correlation of PON1 with the risk …
Can we rely on PET in the follow-up of advanced seminoma patients?
J Siekiera, B Małkowski, W Jóźwicki, M Jasiński… - Urologia …, 2012 - karger.com
The management of residuals after completion of chemotherapy in advanced seminoma is
controversial. It has been proposed that fluorodeoxyglucose-positron emission tomography (…
controversial. It has been proposed that fluorodeoxyglucose-positron emission tomography (…
[HTML][HTML] Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
MW Slupski, C Szczylik, MK Jasinski - World Journal of Surgical Oncology, 2007 - Springer
Background Cholangiocellular cancers account for about 10-15% of primary liver cancers.
Prognosis is poor, with expected survival of less than 5% at five-year. Case presentation The …
Prognosis is poor, with expected survival of less than 5% at five-year. Case presentation The …
Long‐term results of simultaneous and delayed liver resections of synchronous colorectal cancer liver metastases
M Slupski, M Jasinski, S Pierscinski… - ANZ Journal of …, 2020 - Wiley Online Library
Background Complete resection is the only potential curative treatment of synchronous
colorectal liver metastases. Although simultaneous liver and colon resections became an …
colorectal liver metastases. Although simultaneous liver and colon resections became an …
[HTML][HTML] Perioperative and Oncological Outcomes of Percutaneous Radiofrequency Ablation versus Partial Nephrectomy for cT1a Renal Cancers: A Retrospective …
M Jasinski, P Wisniewski, M Bielinska, J Siekiera… - Cancers, 2024 - mdpi.com
Simple Summary Ultrasonography-guided percutaneous radiofrequency ablation is an
attractive alternative treatment method for patients with small renal tumours. It has been …
attractive alternative treatment method for patients with small renal tumours. It has been …
Lymph node dissection during laparoscopic (LRC) and open (ORC) radical cystectomy due to muscle invasive bladder urothelial cancer (pT2-3, TCC)
…, A Wronczewski, K Krasnicki, M Jasinski - Videosurgery and other …, 2011 - termedia.pl
Aim: The aim of the study was to compare the number of nodes dissected during laparoscopic
and open radical cystoprostatectomy in men or anterior exenteration in women due to …
and open radical cystoprostatectomy in men or anterior exenteration in women due to …
Radiofrequency ablation of small renal masses as an alternative to nephron-sparing surgery: preliminary results
M Jasinski, J Siekiera, P Chlosta… - Videosurgery and Other …, 2011 - termedia.pl
Results: In 20 patients kidney tumour was biopsied before radiofrequency ablation (RFA)
and 10 of these biopsies were positive and revealed cancer. Six patients required additional …
and 10 of these biopsies were positive and revealed cancer. Six patients required additional …
Radiofrequency ablation of small renal masses in comorbid patients
J Siekiera, M Jasinski, W Mikołajczak - Videosurgery and Other …, 2018 - termedia.pl
Results The 1, 3 and 5-year overall survival rates were respectively 97%, 90% and 75%,
while cancer-specific survival was 100%. No Clavien-Dindo grade≥ 3 complications were …
while cancer-specific survival was 100%. No Clavien-Dindo grade≥ 3 complications were …